Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-24 Sale(A) |
2021-06-04 09:40 am |
NRX Pharmaceuticals Inc. | BRPA | BRAC Lending Group LLC 10% Owner |
869,565 | $0 | $0 | 590,435 (Direct) |
View |
| 2021-05-24 Sale |
2021-05-25 9:17 pm |
NRX Pharmaceuticals Inc. | BRPA | Big Rock Partners Sponsor LLC ACKERMAN RICHARD 10% Owner |
5,435 | $0 | $0 | 619,315 (Indirect) |
View |
| 2021-05-24 Sale |
2021-05-25 8:02 pm |
NRX Pharmaceuticals Inc. | BRPA | BRAC Lending Group LLC 10% Owner |
869,565 | $0 | $0 | 562,435 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-24 Option Award |
2021-06-10 6:48 pm |
N/A N/A |
NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chief Executive Officer 10% Owner |
14,817,329 | $0 | 1,468,332 (Direct) |
View |
| 2021-05-24 Option Award |
2021-06-10 6:48 pm |
N/A N/A |
NRX Pharmaceuticals Inc. | NRXP | Javitt Daniel C. 10% Owner |
13,971,864 | $0 | 13,971,864 (Indirect) |
View |
| 2021-05-24 Option Award |
2021-06-10 6:47 pm |
N/A 2021-09-01 |
NRX Pharmaceuticals Inc. | NRXP | Hurvitz Chaim Director |
1,863,216 | $0 | 426,866 (Indirect) |
View |
| 2021-05-24 Option Award |
2021-06-10 6:47 pm |
N/A N/A |
NRX Pharmaceuticals Inc. | NRXP | Gorovitz Aaron Director |
25,014 | $0 | 16,678 (Indirect) |
View |
| 2021-05-24 Option Award |
2021-06-10 6:46 pm |
N/A 2026-01-01 |
NRX Pharmaceuticals Inc. | NRXP | Glied Sharon Director |
78,605 | $0 | 78,605 (Direct) |
View |
| 2021-05-24 Option Award |
2021-06-10 6:46 pm |
N/A 2030-11-14 |
NRX Pharmaceuticals Inc. | NRXP | Fricker William CFO & Treasurer |
198,400 | $0 | 297,600 (Direct) |
View |
| 2021-05-24 Option Award |
2021-06-10 6:46 pm |
N/A 2025-10-22 |
NRX Pharmaceuticals Inc. | NRXP | Flynn Patrick John Director |
1,782,819 | $0 | 1,420,487 (Indirect) |
View |
| 2021-05-24 Option Award |
2021-06-10 6:45 pm |
N/A 2030-09-01 |
NRX Pharmaceuticals Inc. | NRXP | Daigneault Alessandra General Counsel & Secretary |
348,560 | $0 | 348,560 (Direct) |
View |
| 2021-05-24 Option Award |
2021-06-10 6:44 pm |
N/A 2026-03-01 |
NRX Pharmaceuticals Inc. | NRXP | Besthof Robert Chief Comm. & Patient Officer |
694,400 | $0 | 694,400 (Direct) |
View |
| 2021-05-24 Conversion |
2021-05-25 9:17 pm |
N/A N/A |
NRX Pharmaceuticals Inc. | BRPA | Big Rock Partners Sponsor LLC ACKERMAN RICHARD 10% Owner |
299,750 | $0 | 619,315 (Indirect) |
View |